• Simplicity, Versatility, Targeted Delivery
  • We offer a versatile catheter system for use with both standard and developing therapeutic agents.
  • RenovoRx was honored at TiEcon on May 18th, 2013 as one of the only three winning startups in the Life Sciences vertical.

About RenovoRX

RenovoRx is a medical device company headquartered in Silicon Valley, California.

We are developing solutions for targeted delivery of therapeutic and diagnostic agents

to selected sites in the peripheral vascular system.

RenovoCath™ Catheter System

We do catheters differently. This video shows the RenovoCath RC120 special features and the role these features play in delivering therapeutic agents to targeted regions.


Read More!

In the News

view all
  • RenovoRx Attending “Y-90: The Complete Course”

    “Y-90: The Complete Course” is the only educational opportunity dedicated to Authorized User and Advanced practice of Y-90 treatment of hepatic malignancies. It is the most comprehensive and challenging radioembolization learning experience available to interventional radiologists and trainees. RenovoRx will … Continue reading

    Read More
  • Visit RenovoRx at the Gastrointestinal Cancers Symposium

    The Gastrointestinal Cancers Symposium is a high-profile, specialized oncology event designed for the exchange of the latest research and science in cancers of the pancreas, small bowel, and hepatobiliary tract; colon and rectum; and esophagus and stomach. RenovoRx will be … Continue reading

    Read More
  • RenovoCath™ RC120 Receives FDA 510(k) Clearance

    Menlo Park, CA (October 30, 2014) – RenovoRx, a leading developer of innovative solutions for targeted delivery of fluids to selected sites in the vascular system, today announced the company has received FDA 510(k) clearance of its flagship product, the … Continue reading

    Read More

Balloon Placement

Optimized design for targeted balloon placement

Contact Delivery

Contact delivery of therapeutic agents